SCHEMBL24199867

SCHEMBL24199867

CCc1ccc(C(=O)c2cc(C)c(OC)cc2Br)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.45
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
ACHE P22303 1/20 0.41
KMT2A Q03164 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
PKM P14618 1/20 0.40
HSD17B2 P37059 1/20 0.40
PLK1 P53350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362509 0.95 MAPT (0.45) HTTMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL24199843 0.86 MAPT (0.51) HTTMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL1253373 0.85 MAPT (0.44) HTTMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL21362793 0.82 PKM (0.49) MAPTSMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL21362512 0.81 MAPT (0.42) HTTMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL20158002 0.80 MAPT (0.50) HTTMAPTALDH1A1NPC1RAB9A
SCHEMBL1252259 0.79 NPC1 (0.55) HTTMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL11813707 0.79 ACHE (0.56) HTTMAPTSMN1; SMN2ALDH1A1HPGD
SCHEMBL20643043 0.78 MAPT (0.48) HTTMAPTSMN1; SMN2ALDH1A1TP53
SCHEMBL20158003 0.78 ALDH1A1 (0.46) HTTMAPTALDH1A1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939577-A1 PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOPYRANOSYL-SUBSTITUTED BENZENE DERIVATIVE Boehringer Ingelheim International GmbH (DE) 2022-01-19 EP disclosed